Cliramitug
Based on 1 Customer Validation
Cliramitug (NI-006; ALXN2220) is a monoclonal antibody that targets human transthyretin (TTR). Cliramitug binds to TTR and inhibits its amyloidogenic process, exerting amyloid formation-inhibiting activity. Cliramitug can be used in the research of transthyretin amyloidosis-related diseases, such as certain neurological and cardiovascular diseases.
For research use only. We do not sell to patients.
- Purity: 97.0%
- CAS No.: 2965214-50-8
- Molecular Weight:144.542 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Human IgG1 kappa
Human
Transthyretin/TTR
Cliramitug accelerates phagocyte-mediated clearance of dense-structured ATTR amyloid fibrils in vitro[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
IgG1-kappa
ELISA, FACS, Functional assay
Chemical Information
-
CAS No. 2965214-50-8
-
Appearance Liquid
-
Molecular Weight 144.542 kDa
-
Color Colorless to light yellow
-
SMILES
[Cliramitug]
-
Synonyms
NI-006; ALXN2220
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (255 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
- Cliramitug
- 2965214-50-8
- NI-006
- ALXN2220
- NI006
- NI 006
- ALXN2220
- ALXN 2220
- ALXN-2220
- Transthyretin (TTR)
- TTR monomers
- macrophage-mediated phagocytosis
- TTR amyloid fibrils
- transthyretin cardiac amyloidosis
- patient-derived fibril xenograft mice
- phagocyte-mediated clearance
- ATTR amyloid fibrils
- conformationally exposed peptide epitope
- cardiac amyloid deposits
- TTR tetramers
- Inhibitor
- inhibitor
- inhibit